Acquire professional services to complete the clinical and analytical components of the pharmacokinetic ?polyethylene glycol safety in children? Study.
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40120C00061
- Awardee
-
The Children's Hospital Of Philadelphia UEI G7MQPLSUX1L4
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $366,992
Award facts
- Opportunity
-
- FDARFP201223424 Solicitation number
- Procure a Safety Study for use of Polyethylene Glycol in Children Award Notice · Posted Apr 14, 2021
- Contract value 53% obligated
-
- $366,992.00 Current, with exercised options
- $692,799.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541618 Other Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Additional Work (new agreement, FAR part 6 applies) | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $41,099 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $325,893 |
Show all 11
About this award
This is a $692,799.00 definitive contract awarded by the Food and Drug Administration (FDA) to The Children's Hospital of Philadelphia (CHOP) to acquire professional services to complete the clinical and analytical components of the "Polyethylene Glycol Safety in Children" pharmacokinetic study. The contract is a cost-no-fee arrangement with a completion date of September 14, 2025. CHOP, a renowned pediatric medical center and research institution, will provide specialized medical research and clinical trial services to the FDA through this contract. There is no set-aside designation for this award.
Quick answers
Who was awarded contract 75F40120C00061?
75F40120C00061 was awarded to The Children's Hospital Of Philadelphia by Food and Drug Administration (Department of Health and Human Services) on September 4, 2020.
How much is contract 75F40120C00061 worth?
The government has obligated $366,992 on 75F40120C00061. Its potential value, with all options, is $692,799.
Was contract 75F40120C00061 competed?
The extent of competition for 75F40120C00061 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award